Pantoprazole Noridem (Pantoprazole)

Pantoprazole Noridem is a proton pump inhibitor used to manage disorders that involve excess stomach acid production.

• Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the oesophageal lining.
• Erosive oesophagitis: facilitates ulcer healing and prevents recurrence.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumours.
• Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence risk.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

• Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly reduces gastric acidity, allowing mucosal healing and symptom relief in acid‑related disorders.

Pantoprazole Noridem is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: usually self‑limiting.
• Nausea or vomiting: transient gastrointestinal upset.
• Abdominal pain: mild discomfort.
• Flatulence: excess gas.
• Constipation: occasional bowel habit change.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhoea.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.
• Liver enzyme elevation: abnormal liver function tests.
• Acute interstitial nephritis: kidney inflammation.

When prescribing Pantoprazole Noridem, clinicians should consider several safety aspects.

• Renal impairment: dose adjustment may be required in severe kidney disease.
• Hepatic impairment: monitor liver function in patients with liver disease.
• Long‑term use: assess need periodically to avoid unnecessary exposure.
• Drug interactions: review concomitant medications for potential CYP‑related effects.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation.
• Store at below 25°C: keep in the original packaging, protect from moisture and light.

Pantoprazole Noridem can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH.
• HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, monitor coagulation.
• Methotrexate: reduced renal clearance, watch for toxicity.
• Digoxin: possible increase in serum levels.
• Clopidogrel: diminished antiplatelet effect, consider alternative therapy.